ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
*
Home
Press release
Nov 08, 2019 19:00 JST
Source:
Holista CollTech Ltd
iGalen and Holista announce resolution with ATM Metabolics
PERTH, W AUSTRALIA, Nov 08, 2019 - (ACN Newswire) - Holista, a research-driven biotech company that develops natural ingredient and wellness products, and its distributor iGalen are pleased to announce that they have resolved their disputes with ATM Metabolics and its founder Dr. Joseph Ahrens, a two time Nobel prize nominee and discoverer of Emulin. As a result, they will no longer be carrying Emulin.
If you would like to purchase the product in the future, please contact ATM at www.atmmetabolics.com. We wish ATM and Dr. Ahrens success in their future endeavours, and thank them for working with us to resolve the disputes.
Holista CollTech (ASX:HCT) is a research-driven biotech company. Headquartered in Perth with operations in Malaysia, it is dedicated to delivering first-class natural ingredients and wellness products globally. Holista's ingredients include low-GI baked products, reduced-sodium salts, low-fat fried foods and low calorie sugar. www.holistaco.com.
iGalen markets a range of premium-quality nutritional supplements that are sold directly to Distributors and Preferred Customers throughout the United States, Canada, Australia, New Zealand, Singapore, Mexico, Malaysia, and the Philippines. Visit www.igalen.com.
Source: Holista CollTech Ltd
Sectors: BioTech, Healthcare & Pharm
Copyright ©2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
Latest Release
Hitachi High-Tech Announces the SU9600: Next-Generation Ultrahigh-Resolution Scanning Electron Microscope with High Throughput
Nov 01, 2025 00:45 JST
Sharp to Introduce AQUOS sense10 Smartphone
Nov 01, 2025 00:27 JST
Fujitsu to provide digital ticketing service for NTT DOCOMO's new d ticket platform
Nov 01, 2025 00:07 JST
HTD1801, a First-in-Class Anti-inflammatory Metabolic Modulator, Demonstrates Durable 52-Week Efficacy and Safety in Two Phase III Trials in Type 2 Diabetes Mellitus
Oct 31, 2025 09:30 JST
MHI and Nippon Shokubai to Develop Ammonia Cracking System for NEDO's "Development of Technologies for Building a Competitive Hydrogen Supply Chain" Project
Oct 30, 2025 23:14 JST
NEC and e& Sign MoU to Drive Joint Sustainability Initiatives
Oct 30, 2025 22:46 JST
MHI Thermal Systems Launches Two New Models of Air-to-Water Heat Pumps Using Natural Refrigerant R290 for European Market
Oct 30, 2025 22:19 JST
Hitachi Energy and Blackstone Energy Transition Partners enter strategic partnership to create leading energy service provider in North America
Oct 30, 2025 21:40 JST
MHI-MS to Conduct Demonstration Testing of Vehicle Transport Robots at Nakagusuku Port in Okinawa
Oct 30, 2025 17:58 JST
DENSO Hosted a Press Briefing at JAPAN MOBILITY SHOW 2025
Oct 30, 2025 17:29 JST
Eisai and Merck & Co., Inc., Rahway, NJ, USA Provide Update on Phase 3 LEAP012 Trial in Unresectable, Non-Metastatic Hepatocellular Carcinoma
Oct 30, 2025 14:43 JST
Mazda Presents World Premiere of Two Vision Models at Japan Mobility Show 2025
Oct 30, 2025 14:33 JST
Mazda Rolls Out New Version of Brand Symbol from Japan Mobility Show 2025
Oct 30, 2025 14:26 JST
NEC and the Cambodian Mine Action Center Successfully Predict Landmine-Contaminated Areas in Cambodia Using AI
Oct 30, 2025 14:18 JST
Overview of Honda CEO Speech at the Japan Mobility Show 2025
Oct 30, 2025 14:00 JST
Honda Presents World Premiere of the Prototype of Honda 0 a, new SUV Model for Honda 0 Series at Japan Mobility Show 2025
Oct 30, 2025 11:55 JST
Honda Presents World Premiere of Super-ONE Prototype Compact EV at Japan Mobility Show 2025
Oct 30, 2025 11:50 JST
Mitsubishi Motors Debuts Mitsubishi Elevance Concept and Adventure-Inspiring Lineup at Japan Mobility Show 2025
Oct 30, 2025 11:39 JST
Fujitsu and PwC Japan partner on economic security measures for sovereign cloud solution
Oct 30, 2025 11:22 JST
Hitachi Rail becomes world's first transportation firm to adopt new NVIDIA IGX Thor solution for real-time AI
Oct 30, 2025 11:00 JST
More Latest Release >>
Related Release
Berjaya Partners Holista to Offer Healthy Breads and Foods in Starbucks Malaysia, 7-Eleven and Other F&B Outlets
October 12 2021 17:00 JST
Malaysia Permission Granted for COVID-19 Test Kit from China for Emergency Use; Homegrown Holista Colltech Receives Initial Order for 15,000 Units for Deployment
June 18 2021 14:00 JST
US Tests Confirm Path-Away(R) Organically Kills SARS-CoV-2 Virus
October 21 2020 21:00 JST
Holista Signs Agreement with Costanzo's to Launch World's Lowest Glycaemic Index (GI) Clean Label Bread
October 01 2020 15:00 JST
Path-Away(R), Active Ingredient in Plant-Based, Alcohol-Free NatShield(TM) Hand Sanitiser by Holista CollTech, Tested >99.99% Effective against COVID-19 Surrogate
April 21 2020 06:30 JST
Skin Elements Enters Binding Agreement with Holista Colltech To Launch All Natural Skin-Friendly Sanitiser
April 03 2020 17:00 JST
Holista Partners GICC LLC, the U.S. Developer of Path-Away(R), to Co-Develop Nasal Sanitising Balm for Global Markets
February 20 2020 16:00 JST
Malaysians Rush for Anti-Virus Sanitiser, NatShield(TM), after Pharmacies Restock on Concerns of Spread of Deadly Disease
February 06 2020 16:00 JST
Orders for NatShield Sanitizer Spike after Outbreak of Coronavirus
January 30 2020 16:00 JST
Holista Files Patent for Water-Soluble Technology Targeting Cannabidiol (CBD) and Fat-Soluble Nutraceuticals
December 13 2019 13:00 JST
More Press release >>